Sequoia China-backed ArriVent Biopharma raises $150m in upsized US IPO

Sequoia China-backed ArriVent Biopharma raises $150m in upsized US IPO

Photographer: Victor J. Blue/Bloomberg

Mars W. Mosqueda Jr.

30 January, 2024

Edited by: Padma Priya

Allist PharmaceuticalsArriVent Biopharma

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

You may also like

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.